The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Matt Mead appointed Chief Investment Officer

25 Mar 2015 07:00

RNS Number : 3573I
Mercia Technologies PLC
25 March 2015
 



25 March 2015

 

Mercia Technologies PLC

 

Matt Mead appointed Chief Investment Officer

 

Mercia Technologies PLC (AIM: MERC, "Mercia" or the "Group"), a Midlands based leader in the funding and commercialisation of technology businesses in the UK, is pleased to announce that Matt Mead has been appointed Chief Investment Officer with effect from 26 May 2015.

 

Matt has over 20 years' experience in the investment industry and is a seasoned board executive, having been a non-executive director and non-executive Chairman at over 15 early stage and growth businesses.

 

He worked at 3i from 1995 to 2009 making early stage investments in software and other technology businesses. He also successfully directed 3i's pan European Venture portfolio team returning a significant level of proceeds in two years and managed the disposal of 3i's Venture Portfolio in a series of secondary transactions.

 

He subsequently joined NESTA as Managing Director Investments to run its £30m Venture Capital Fund and in 2010 was appointed CIO, managing all investment activity at NESTA, including its £350m Trust assets and its social impact investment funds.

 

Mark Payton, Chief Executive of Mercia Technologies PLC, said:

 

"I am delighted to welcome Matt to Mercia Technologies as CIO. He has an excellent track record in all stages of the investment process - from identifying quality early stage opportunities, through to nurturing and scaling growth businesses for successful exit.

 

"With his broad expertise and experience, backed by a strong reputation as a smart and effective investor in emerging, innovative businesses, Matt is a valuable addition to our executive team, as we continue to develop our business into 2015."

 

 

Enquiries:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu / Mark Connelly

Instinctif Partners

+44 (0) 20 7457 2020

Adrian Duffield / Kay Larsen

 

Other than the following details, there are no further details in relation to Matthew Mead to be disclosed under Rule 17 and Schedule 2 paragraph (g) of the AIM Rules.

 

Matthew Sidney Mead aged 50, is currently a director of the following companies:

 

· Kiln Ventures Limited

· Cogbooks Limited

 

During the five year period up to the date of this announcement Mathew has also served as a director of the following companies of which he is no longer a director:

 

· Nesta Partners limited

· Nesta GP Limited

· UK Business Angels Association

· Featurespace limited

· Movellas APS

 

Note to editors

 

Mercia Technologies PLC

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands and the North of the UK. It brings technology transfer, company formation, incubation, commercialisation and investment, to technology ventures.

 

Mercia has a well seeded portfolio and pipeline of investments. The Group has a direct investment in 11 operating companies and access to a portfolio of 38 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.

 

Mercia's shares started trading on AIM on 18 December 2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEUFMLFISEID
Date   Source Headline
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.